Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer

Gemcitabine has been used as first-line chemotherapy against lung cancer, but many patients experience cancer recurrence. Activation of anti-tumor immunity in vivo has become an important way to prevent recurrence. Anti-tumor immune responses are often dependent upon the immunogenicity of tumors. In...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Immunol
Hoofdauteurs: Zhang, Xin, Wang, Dong, Li, Zhidong, Jiao, Defeng, Jin, Linlin, Cong, Jingjing, Zheng, Xiaohu, Xu, Lijun
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2020
Onderwerpen:
Immunology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7052388/
https://ncbi.nlm.nih.gov/pubmed/32161598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00331
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items